FHIR Release 3 (STU) CI-Build

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0 . For a full list Continuous Integration Build of available versions, see FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationexample0306

Example Medication/med0306 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Ballot Standards Status : Informative Compartments : Not linked to any No defined compartments

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile Medication .

Generated Narrative with Details Narrative: Medication med0306

id : med0306 contained :

code : Adcetris (Details : {http://hl7.org/fhir/sid/ndc code '51144-050-01' = '51144-050-01', given as 'Adcetris'})

isBrand marketingAuthorizationHolder : true Organization Medication Manufacturer manufacturer : id: org3; name: Seattle Genetics Inc

form doseForm : Lyophilized Lyophilised powder for injectable conventional release solution (qualifier value) (Details : {SNOMED CT code '421637006' = 'Lyophilised powder for injectable solution', given as 'Lyophilized powder for injectable solution (qualifier value) '}) injection

package

Batches Instances

- Identifier LotNumber ExpirationDate
* http://hl7.org/fhir/sid/gs1-128 /(01)00351144050016(10)A1234(17)251031(21)SN987654321 12345 31/10/2019 2019-10-31

Generated Narrative: Organization #mmanu

name : Medication Manufacturer

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.